ZS3-046
ZS3-046 is a potent TAF1 PROTAC degrader with a DC50 < 10 nM. ZS3-046 recruits the CRBN E3 ubiquitin ligase, promotes polyubiquitination and proteasomal degradation of TAF1, thereby activating p53 and downregulating c-Myc, and ultimately induces apoptosis of tumor cells. ZS3-046 can be used in research related to acute myeloid leukemia.
(Pink: TAF1 ligand (HY-176467); Blue: Cereblon ligand (HY-41547); Black: linker (HY-176469)).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3087879-97-5
- Formel: C49H57N9O7
- Molecular Weight:884.03
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Protokoll
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Alle PROTACs Isoform-spezifische Produkte anzeigen
MoreAlle DNA/RNA Synthesis Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
TAF1 < 10 nM (DC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MOLM-13 | DC50 |
< 10 nM
|
Half-maximal degradation of TAF1 in unspecified cancer cell lines.
Half-maximal degradation of TAF1 in unspecified cancer cell lines.
|
40376796 |
In Vitro
ZS3-046 (< 10 nM) potently induces TAF1 degradation in cancer cell lines with a DC50 < 10 nM[1].
ZS3-046 (100 nM; 8 h) treatment of Molm13 AML cells alters expression of 4380 genes, including p53 targets, reflecting TAF1's role in transcription initiation and complex regulation of p53 activity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Molm13 cell
-
Concentration:2, 10, 50, 250 nM
-
Incubation Time:18 h
-
Result:Potently degraded TAF1 protein in a concentration-dependent manner.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Athymic Nude-Foxn1nu (female, 6-week old, subcutaneously injected with HL60 cells to induce acute myeloid leukemia)[1]
-
Dosage:5, 10 mg/kg
-
Administration:i.p.; once every 4-5 days; 4 total injections; for 14 days
-
Result:Tumor growth was significantly inhibited following treatment with doses of 5 mg/kg and 10 mg/kg.
No significant weight loss was observed throughout the dosing and observation periods, indicating good tolerability and an absence of apparent toxicity.
Chemical Information
-
CAS. Nr. 3087879-97-5
-
Molecular Weight 884.03
-
Formel C49H57N9O7
-
SMILES
O=C(N1C2CCC(NC2=O)=O)C3=C(NCC4CCN(CCCCCCCN5C6=C(C(C(C7=C8NC=C7)=CN(CCC=C)C8=O)=CC(C(N9CCOCC9)=O)=C6)N=C5)CC4)C=CC=C3C1=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
ZS3-046 Related Classifications
HY-176457 Related Classifications
Powered by Bioz